Orchestra BioMed Holdings, Inc. operates as a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. It offers BackBeat Cardiac Neuromodulation Therapy (CNT), a patented, intelligent bioelectronic treatment for hypertension; Virtue SAB, a patented drug/device combination product for the treatment of artery disease; FreeHold Retractors, a minimally invasive surgical device solution; and Virtue SEB, a drug-eluting balloon angioplasty system for the treatment of coronary artery disease. The company has a strategic collaboration with Medtronic to develop BackBeat CNT as a potential treatment for hypertension in patients who are indicated for a cardiac pacemaker. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
Orchestra BioMed Holdings, Inc. operates as a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. It offers BackBeat Cardiac Neuromodulation Therapy (CNT), a patented, intelligent bioelectronic treatment for hypertension; Virtue SAB, a patented drug/device combination product for the treatment of artery disease; FreeHold Retractors, a minimally invasive surgical device solution; and Virtue SEB, a drug-eluting balloon angioplasty system for the treatment of coronary artery disease. The company has a strategic collaboration with Medtronic to develop BackBeat CNT as a potential treatment for hypertension in patients who are indicated for a cardiac pacemaker. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.